Moreover, more accurate modelling of the in vivo tumour environment with 3D culture methods allows the validation of founder (HRAS transformation) and acquired (PIK3CA and TP53 mutations) events that would not have been appreciated with traditional techniques. This evidence concerns the gene PIK3CA and neoplasm.